EpiReumaPt was supported by a grant from Direcção-Geral da Saúde and was sponsored by: Fundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbott, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Centro de Medicina Laboratorial Germano de Sousa, CAL-Clínica, Galp Energia, Açoreana Seguros and individual Rheumatologists.

View Statistics Email Alert RSS Feed

Primary Data

Project title
EpiReumaPt was supported by a grant from Direcção-Geral da Saúde and was sponsored by: Fundação Calouste Gulbenkian, Fundação Champalimaud, Fundação AstraZeneca, Abbott, Merck Sharp & Dohme, Pfizer, Roche, Servier, Bial, D3A Medical Systems, Happybrands, Centro de Medicina Laboratorial Germano de Sousa, CAL-Clínica, Galp Energia, Açoreana Seguros and individual Rheumatologists.

Publications
(All)

Results 1-1 of 1 (Search time: 0.001 seconds).

Issue DateTitleAuthor(s)TypeAccess
12016Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health surveyBranco, Jaime C.; Rodrigues, Ana M.; Gouveia, Nélia ; Eusébio, Mónica; Ramiro, Sofia; Machado, Pedro ; da Costa, Leonor Pereira; Mourão, Ana Filipa; Silva, Inês; Laires, Pedro; Sepriano, Alexandre; Araújo, Filipe; Gonçalves, Sónia ; Coelho, Pedro S.; Tavares, Viviana; Cerol, Jorge; Mendes, Jorge M.; Carmona, Loreto; Canhão, HelenaarticleopenAccess